NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/11/2025
Back to search
Official data from USPTO
VAPOURSOFT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
52
Latest update
12/12/2025
Trademark type
Word
Nice classes
10
Filing date
01/29/2014
Registration date
09/22/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/08/2022
Last transaction
12/12/2025
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
BUONGIORNO,CHRISTOPHER L
Law office
L20
Current location
TMEG LAW OFFICE 103
Holders and representatives
Holders
Consort Medical Limited
Consort Medical Plc
Representatives
Norm J. Rich Foley & Lardner LLP
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Hydrofluoroalkanes (HFA) powered and liquefied gas powered apparatus and instruments for use in or in relation to drug and pharmaceutical delivery deviceshydrofluoroalkanes (HFA) powered drug delivery systems in the nature of infusion and injection devices for administering drugs; hydrofluoralkanes (HFA) powered medical syringesmedical fluid auto-injectors for administrating pharmaceuticals and drugs and apparatus and devices for the inhalation or injection of pharmaceuticals and drugs; hydrofluoroalkanes (HFA) powered devicesapparatus and instruments for use with drug and pharmaceutical delivery devices that convey drug and pharmaceutical delivery dosagemeasuring and monitoring information through audiovisual and/or tactile patient feedback mechanisms; hydrofluoralkanes (HFA) powered medical syringesmedical fluid auto-injectors and apparatus and devices in the nature of drug delivery systems incorporating audiovisual and/or tactile patient feedback mechanisms to convey dosagemeasuringmonitoring data for the purpose of facilitating and monitoring drug and pharmaceutical delivery and administration; medical syringes; medical syringe stoppers; medical fluid auto-injectors; medical fluid injectors; disposable syringes and medical fluid injectors; hypodermic syringes; apparatus and devices for administering pharmaceuticals and drugsmedical apparatus in the nature of infusion and injection devices for administering drugsmedical tubing for administering drugshypodermic needles; sterile medical syringes and medical fluid auto-injectors for the administration of pharmaceuticals and drugs; cartridges for medical syringes; nozzles for medical syringes; drug delivery apparatusdrug delivery systemselectromagnetic drug delivery apparatus for medical use; oral and nasal medication dispensersnasal aspiratorsaerosol dispensers for medical use; aerosol dispensers for medical purposes; parts and fittings for all the aforesaid
Publications
History of USPTO decisions and trademark events.
52 publications found
Further Decision Processed by IB
04/26/2025
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
02/25/2025
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
02/25/2025
XXCR
GENERIC MADRID TRANSACTION CREATED
02/25/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
02/29/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
12/08/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/22/2022
GPNX
NOTIFICATION PROCESSED BY IB
10/31/2022
RFNT
REFUSAL PROCESSED BY IB
04/10/2022
C71T
CANCELLED SECTION 71
04/08/2022
WDRL
OTQR WITHDRAWAL FROM PUBLICATION
12/21/2021
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
12/10/2021
XXXX
POST REGISTRATION ACTION CORRECTION
12/10/2021
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
11/03/2021
RFNT
REFUSAL PROCESSED BY IB
07/18/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
10/09/2020
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/22/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/26/2016
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/19/2016
FIMP
FINAL DISPOSITION PROCESSED
03/19/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/22/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
09/22/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/07/2015
PUBO
PUBLISHED FOR OPPOSITION
07/07/2015
GPNX
NOTIFICATION PROCESSED BY IB
07/03/2015
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/17/2015
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/17/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/17/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/04/2015
ALIE
ASSIGNED TO LIE
06/03/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/12/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
05/11/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/11/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
05/11/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/11/2015
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/09/2014
GNFR
FINAL REFUSAL E-MAILED
12/09/2014
CNFR
FINAL REFUSAL WRITTEN
12/09/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/14/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/13/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/13/2014
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/07/2014
RFNT
REFUSAL PROCESSED BY IB
06/20/2014
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/27/2014
RFRR
REFUSAL PROCESSED BY MPU
05/27/2014
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/25/2014
CNRT
NON-FINAL ACTION WRITTEN
05/24/2014
MAFR
APPLICATION FILING RECEIPT MAILED
05/23/2014
DOCK
ASSIGNED TO EXAMINER
05/19/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/19/2014
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/15/2014
Continuous trademark protection
Get notified about every new filing that threatens VAPOURSOFT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.